Selenium as a Potential Treatment for Moderately-ill, Severely-ill, and Critically-ill COVID-19 Patients

Ghoweba et al., NCT04869579, SeCOVID, NCT04869579, Dec 2021
Estimated 100 patient selenium late treatment RCT with results not reported over 4 years after estimated completion.
Ghoweba et al., 15 Dec 2021, Double Blind Randomized Controlled Trial, USA, trial NCT04869579 (history) (SeCOVID). Contact: mohamed.ghoweba@christushealth.org.
Late treatment
is less effective
Please send us corrections, updates, or comments. c19early involves the extraction of 200,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. IMA and WCH provide treatment protocols.
Submit